Mediwound Ltd Revenue Growth Rates (MDWD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Mediwound Ltd   (NASDAQ: MDWD)
 

MDWD's Revenue Growth by Quarter and Year

Mediwound Ltd 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDWD Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 16.96
3rd Quarter September 0.00
2nd Quarter June 5.71
1st Quarter March 0.00
FY 22.67

MDWDs Annual Revenue
Mediwound Ltd 's Revenue in the fiscal year 2025 $ 16.96 millions
Mediwound Ltd 's Revenue in the fiscal year 2024 $ 20.22 millions
Mediwound Ltd 's Revenue in the fiscal year 2023 $ 18.69 millions
Mediwound Ltd 's Revenue in the fiscal year 2022 $ 26.50 millions
Mediwound Ltd 's Revenue in the fiscal year 2021 $ 23.76 millions




MDWD Revenue fourth quarter 2025 Y/Y Growth Comment
Mediwound Ltd reported decline in Revenue in the fourth quarter 2025 by -16.13% to $ 16.96 millions, from the same quarter in 2024.
The contraction in the fourth quarter 2025 Mediwound Ltd 's Revenue compares unfavorably to the Company's average Revenue doubling of 188.26%.

Looking into fourth quarter 2025 results within Legal Cannabis industry 14 other companies have achieved higher Revenue growth. While Mediwound Ltd ' s Revenue fall of -16.13% ranks overall at the positon no. 3672 in the fourth quarter 2025.


MDWD Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December -16.13 % - - 15.88 %
3rd Quarter September - - - -
2nd Quarter June 12.85 % 6.08 % -78.08 % -31.55 %
1st Quarter March - - - -
FY   -10.33 % 429.98 % -85.32 % -

Financial Statements
Mediwound Ltd 's fourth quarter 2025 Revenue $ 16.96 millions MDWD's Income Statement
Mediwound Ltd 's fourth quarter 2024 Revenue $ 20.22 millions Quarterly MDWD's Income Statement


MDWD Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -22.94 %
3rd Quarter September - - - -72.15 %
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   -10.33 % 429.98 % -85.32 % -


Back to MDWD Growth rate Comparisons >> Back to MDWD Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #15
Consumer Non Cyclical Sector #147
Overall #3672

Revenue Y/Y Growth Statistics
High Average Low
1912.22 % 188.26 % -80.59 %
(Dec 31 2019)   (Dec 31 2020)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #15
Consumer Non Cyclical Sector #147
Overall #3672
Revenue Y/Y Growth Statistics
High Average Low
1912.22 % 188.26 % -80.59 %
(Dec 31 2019)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Mediwound Ltd 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MDWD's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MDWD's IV. Quarter Q/Q Revenue Comment


Mediwound Ltd 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 16.96 $ 20.22 $ 18.69 $ 26.50 $ 23.76
Y / Y Revenue Growth (TTM) -16.14 % 8.22 % -29.48 % 11.5 % 9.19 %
Year on Year Revenue Growth Overall Ranking # 4 # 0 # 8 # 0 # 0
Seqeuential Revenue Change (TTM) -16.14 % 8.22 % -29.48 % 11.5 % 9.19 %
Seq. Revenue Growth (TTM) Overall Ranking # 4 # 0 # 8 # 0 # 0


Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2025 Mediwound Ltd reported a fall in Revenue by -16.14% year on year, to $17 millions, compare to the 8.22% growth at Dec 31 2024.

Looking into Consumer Non Cyclical sector trailing twelve month Revenue increase, only one company had higher growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 4.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 0
Consumer Non Cyclical Sector # 2
Overall # 4

Revenue TTM Y/Y Growth Statistics
High Average Low
2983.32 %
 1475.89 %
-31.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 2
S&P 500 # 4
Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2025 Mediwound Ltd reported a fall in Revenue by -16.14% year on year, to $17 millions, compare to the 8.22% growth at Dec 31 2024.

Looking into Consumer Non Cyclical sector trailing twelve month Revenue increase, only one company had higher growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 4.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 0
Consumer Non Cyclical Sector # 2
Overall # 4

Revenue TTM Y/Y Growth Statistics
High Average Low
2983.32 %
1475.89 %
-31.54 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 2
S&P 500 # 4




Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MDWD's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Dec 31 2025 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Waldencast Plc-0.63%$ -0.631 millions
Anheuser busch Inbev Sa-0.75%$ -0.750 millions
The Clorox Company-0.77%$ -0.771 millions
Ambev S a -1.35%$ -1.349 millions
Willamette Valley Vineyards Inc -1.51%$ -1.505 millions
Altria Group Inc -1.65%$ -1.655 millions
Farmer Brothers Co-1.75%$ -1.750 millions
Cbdmd Inc -1.89%$ -1.889 millions
Ingredion Incorporated-2.39%$ -2.389 millions
Trulieve Cannabis Corp.-2.66%$ -2.656 millions
Seaboard Corporation-2.90%$ -2.901 millions
Kraft Heinz Co-3.38%$ -3.376 millions
Reed s Inc -3.91%$ -3.912 millions
Zevia Pbc-4.03%$ -4.030 millions
J and j Snack Foods Corp -5.22%$ -5.219 millions
Central Garden and Pet Company-5.96%$ -5.962 millions
Adecoagro S a -6.00%$ -6.003 millions
Cvr Partners Lp-6.08%$ -6.084 millions
Golden Growers Cooperative-6.57%$ -6.572 millions
The Hain Celestial Group Inc -6.81%$ -6.808 millions
Biote Corp -6.87%$ -6.875 millions
Molson Coors Beverage Company-7.44%$ -7.444 millions
Universal Corporation-8.10%$ -8.099 millions
American Vanguard Corporation-8.58%$ -8.583 millions
Mannatech Inc-9.30%$ -9.300 millions
Crimson Wine Group Ltd -10.39%$ -10.386 millions
Ascend Wellness Holdings, Inc.-11.37%$ -11.367 millions
22nd Century Group inc -12.01%$ -12.015 millions
Cibus Inc -12.79%$ -12.789 millions
Archer daniels midland Co-13.68%$ -13.685 millions


About Mediwound Ltd Revenue Growth Rates (MDWD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Mediwound Ltd (CIK 1593984).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001178913-26-000749
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Mediwound Ltd ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.